Evidence map›Paper›PMID 38429623›Full record

ArticleMolecular neurobiology2024

Cell-Permeable HSP70 Protects Neurons and Astrocytes Against Cell Death in the Rotenone-Induced and Familial Models of Parkinson's Disease.

Andrey Y Vinokurov, Alexander A Palalov, Kristina A Kritskaya, Svetlana V Demyanenko, David G Garbuz, Michael B Evgen'ev, Noemi Esteras, Andrey Y Abramov

Open access · hybridAbstract read
In one paragraph

Article in Molecular neurobiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Andrey Y VinokurovOrel State University, Orel, Russia.
Alexander A PalalovOrel State University, Orel, Russia.
Kristina A KritskayaInstitute of Cell Biophysics of the Russian Academy of Sciences, 142290, Pushchino, Russia.
Svetlana V DemyanenkoLaboratory of Molecular Neurobiology, Academy of Biology and Biotechnology, Southern Federal University, 344090, Rostov-On-Don, Russia.
David G GarbuzEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991, Moscow, Russia.
Michael B Evgen'evEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991, Moscow, Russia.
Noemi EsterasDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.
Andrey Y AbramovDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK. a.abramov@ucl.ac.uk.ORCID http://orcid.org/0000-0002-7646-7235
Engelhardt Institute of Molecular Biology · RUOrel State University named after I.S. Turgenev · RUInstitute of Cell Biophysics · RUQueen Mary University of London · GBSouthern Federal University · RUUniversidad Complutense de Madrid · ES

Funding

Ministry of Science and Higher Education of the Russian Federation FENW-2023-0018
6 · The paper itself

Abstract

Heat shock protein 70 (HSP70) is activated under stress response. Its involvement in cell protection, including energy metabolism and quality control makes it a promising pharmacological target. A strategy to increase HSP70 levels inside the cells is the application of recombinant HSP70. However, cell permeability and functionality of these exogenously applied proteins inside the cells is still disputable. Here, using fluorescence- labeled HSP70, we have studied permeability and distribution of HSP70 inside primary neurons and astrocytes, and how exogenous HSP70 changes mitochondrial metabolism and mitophagy. We have found that exogenous recombinant HSP70 can penetrate the neurons and astrocytes and distributes in mitochondria, lysosomes and in lesser degree in the endoplasmic reticulum. HSP70 increases mitochondrial membrane potential in control neurons and astrocytes, and in fibroblasts of patients with familial Parkinson´s disease (PD) with PINK1 and LRRK2 mutations. Increased mitochondrial membrane potential was associated with higher mitochondrial ROS production and activation of mitophagy. Importantly, preincubation of the cells with HSP70 protected neurons and astrocytes against cell death in a toxic model of PD induced by rotenone, and in the PINK1 and LRRK2 PD human fibroblasts. Thus, exogenous recombinant HSP70 is cell permeable, and acts as endogenous HSP70 protecting cells in the case of toxic model and familial forms of Parkinson's Disease.

Indexed as

AstrocytesCell DeathHSP70 Heat-Shock ProteinsMembrane Potential, MitochondrialMitochondriaNeuronsParkinson DiseaseRotenoneAnimalsCell Membrane PermeabilityCells, CulturedFibroblastsHumansMitophagyReactive Oxygen SpeciesHSP70 Heat-Shock ProteinsReactive Oxygen SpeciesRotenoneHsp70LysosomesMitochondriaMitophagyParkinson’s Disease

Identifiers

PMID38429623
PMCPMC11415435
OpenAlexW4392345478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.